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Abstract. In the accompanying paper by Weil et al. 
(1996) we show that staurosporine (STS), in the pres- 
ence of cycloheximide (CHX) to inhibit protein synthe- 
sis, induces apoptotic cell death in a large variety of nu- 
cleated mammalian cell types, suggesting that all 
nucleated mammalian cells constitutively express all of 
the proteins required to undergo programmed cell 
death (PCD). The reliability of that conclusion depends 
on the evidence that STS-induced, and (STS+CHS)- 
induced, cell deaths are bona fide examples of PCD. 
There is rapidly accumulating evidence that some 
members of the Ced-3/Interleukin-l[3 converting en- 
zyme (ICE) family of cysteine proteases are part of the 
basic machinery of PCD. Here we show that Z-Val- 
Ala-Asp-fluoromethylketone (zVAD-fmk), a cell- 
permeable, irreversible, tripeptide inhibitor of some of 
these proteases, suppresses STS-induced and 
(STS + CHX)-induced cell death in a wide variety of 
mammalian cell types, including anucleate cytoplasts, 
providing strong evidence that these are all bona fide 
examples of PCD. We show that the Ced-3/ICE family 
member CPP32 becomes activated in STS-induced 
PCD, and that Bcl-2 inhibits this activation. Most im- 
portant, we show that, in some cells at least, one or 
more CPP32-family members, but not ICE itself, is re- 
quired for STS-induced PCD. Finally, we show that 
zVAD-fmk suppresses PCD in the interdigital webs in 
developing mouse paws and blocks the removal of web 
tissue during digit development, suggesting that this in- 
hibition will be a useful tool for investigating the roles 
of PCD in various developmental processes. 
p 
ROGRAMMED cell death (PCD)  1 is the process whereby 
cells activate an intrinsic death program and kill them- 
selves. Two lines of evidence suggest that the death 
program is similar in all animal cells. First, the morpholog- 
ical features of PCD, termed apoptosis, are generally simi- 
lar in all animals that have been studied: in most cases the 
nucleus condenses, the cell shrinks and often fragments, 
and the cells or fragments are  rapidly phagocytosed by 
neighboring cells or by macrophages (Wyllie et al., 1980). 
Second, two genes involved in PCD in the nematode C. el- 
egans have functional and structural homologues in mam- 
malian cells. Ced-3, which is required for PCD in the nem- 
atode (Ellis and Horvitz, 1986), encodes a cysteine protease 
that is homologous to the IL-113 converting enzyme (ICE) 
family of cysteine proteases  in  mammals  (Yuan  et  al., 
1993), some of which are involved in PCD in mammalian 
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ceils:  overexpression of either Ced-3  or ICE can induce 
PCD in mammalian cells (Gagliardini et al., 1994; Miura et 
al., 1993), as can overexpression of other Ced-3/ICE fam- 
ily members (Faucheu et al., 1995; Fernandes-Alnemri et 
al., 1994, 1995a; Kamens et al.,  1995; Kumar et al., 1994; 
Munday et al., 1995; Wang et al., 1994), while protein and 
peptide inhibitors of these proteases can suppress PCD in 
many circumstances (for reviews see Martin and Green, 
1995; Thornberry et al., 1995).  Ced-9, which inhibits PCD 
in the nematode, encodes a protein that is homologous to 
the Bcl-2 protein, which inhibits PCD in mammalian cells 
(Hengartner and Horvitz, 1994); the human bcl-2 gene can 
even inhibit PCD in the nematode. These findings suggest 
that the death program and at least part of its regulation 
have been conserved in evolution from nematode worms 
to mammals. 
In the present study we have examined the role of the 
Ced-3/ICE family of proteases in PCD  induced by high 
concentrations of the broad-spectrum protein kinase in- 
hibitor staurosporine (STS). In other studies we have used 
STS-induced PCD to investigate some fundamental fea- 
tures of PCD in mammalian cells. STS has several advan- 
tages as a PCD inducer. In the presence of cycloheximide 
(CHX) to inhibit protein synthesis, it induces PCD in all of 
the nucleated mammalian cell types that we and others 
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culture (Bertrand et al., 1994; Ishizaki et al., 1993,  1994, 
1995;  Jacobson  et  al.,  1993,  1994),  and  developing and 
adult cells in explant culture (accompanying paper by Weil 
et al. [1996]). As inhibitors of protein synthesis potentiate 
STS-induced PCD, it is clear that PCD does not require 
the synthesis of new proteins, although the activation of 
the death program by some other inducers of PCD clearly 
does so (Duke and Cohen, 1986; Martin et al.,  1988; Op- 
penheim  et  al.,  1990;  Tata,  1966).  We  concluded  from 
these studies that all of the proteins required to execute 
the death program are constitutively present in all nucle- 
ated mammalian cells (accompanying paper by Weil et al. 
[1996]). 
We have also used STS-induced PCD to show that both 
PCD  and Bcl-2 protection can occur in the absence of a 
nucleus (Jacobson et al.,  1994), mitochondrial respiration 
(Jacobson et al., 1993), or reactive oxygen species (Jacob- 
son and Raft, 1995).  These findings led us to suggest that 
PCD is orchestrated by a cytoplasmic regulator that acts in 
parallel on multiple intracellular targets to coordinate the 
many intracellular events that constitute PCD  (Jacobson 
et al., 1994; Jacobson and Evan, 1994). The strongest can- 
didate  for such  a  cytoplasmic regulator is  one or more 
members of the Ced-3/ICE family of proteases. 
Two characteristic features of this family of proteases 
are that they cleave their target proteins after specific as- 
partic acids  (Nicholson et al.,  1995;  Tewari et al.,  1995; 
Thornberry et al., 1992; Xue and Horvitz, 1995), and they 
are themselves activated by cleavage after specific aspartic 
acids, forming two subunits that together form the active 
site  of the enzyme (Faucheu et al.,  1995;  Tewari et al., 
1995; Thornberry et al.,  1992).  In vitro at least, some of 
these proteases  can activate themselves (Faucheu et al., 
1995; Thornberry et al., 1992), and some can activate other 
family members (Faucheu et al., 1995; Tewari et al., 1995), 
suggesting that they can act in a cascade. ICE itself seems 
not to be required for most PCDs in vivo, as mice with tar- 
geted disruptions of the ice gene develop normally, with- 
out an obvious defect in PCD (Kuida et al., 1995; Li et al., 
1995).  There are many other members of the Ced-3/ICE 
family in mammals, however, and any of them could play 
important  roles  in  PCD  (for  reviews  see  Martin  and 
Green, 1995; Kumar, 1995). 
There seems to be at least two emerging subfamilies of 
Ced-3/ICE family proteases, based on their amino acid se- 
quence  and  the  substrates  they  recognize:  those  more 
closely related to ICE, and those more closely related to 
Ced-3 and CPP32 (Thornberry et al.,  1995). ICE, for ex- 
ample,  cleaves  pro-IL-113  and  is  efficiently inhibited  in 
vitro by the tetrapeptide inhibitor Ac-YVAD-CHO (Thom- 
berry et al., 1992), the sequence of which closely resembles 
the pro-IL-113  cleavage site (YVHD); CPP32 cleaves the 
nuclear enzyme poly-(ADP ribose) polymerase (PARP) 
and is efficiently inhibited in vitro by the tetrapeptide in- 
hibitor Ac-DEVD-CHO (Nicholson et al., 1995), the se- 
quence of which corresponds to the PARP cleavage site 
(Lazebnik et al., 1994). Two proteases, Mch2 (Fernandes- 
Alnemri et al.,  1995a) and Mch3/ICE-LAP3 (Duan et al., 
1996;  Fernandes-Alnemri  et  al.,  1995b),  have  recently 
been identified that are more similar to CPP32 and Ced-3 
than to other family members and are capable of cleaving 
PARP  in vitro. Although it is  still uncertain how many 
Ced-3/ICE family members there are and which ones are 
important in PCD in vertebrate cells, there is accumulat- 
ing evidence that CPP32 and/or one or more of its close 
relatives are crucially involved. 
PARP cleavage is a useful indicator of PCD and of the 
activation of CPP32 (or its close relatives) in vitro and in 
vivo. It is cleaved from a  ll6-kD form to an 85-kD frag- 
ment in many examples of PCD  (Gu et al.,  1995; Kauf- 
mann, 1989; Kaufmann et al., 1993; Tewari et al., 1995). It 
is cleaved in the same way by cytoplasmic extracts that in- 
duce apoptotic changes in isolated nuclei in vitro (Lazeb- 
nik et al., 1994), and both the PARP cleavage and nuclear 
changes are prevented if the extracts are treated with pep- 
tide  inhibitors  that  contain  the  PARP  cleavage-site se- 
quence DEVD  (Lazebnik et al.,  1994;  Nicholson et  al., 
1995).  Moreover,  when  this  tetrapeptide  sequence  was 
used in  an  affinity chromatography procedure to purify 
the protein in the extract that is responsible for cleaving 
PARP,  the  purified  protein  was  found  to  be  CPP32 
(Nicholson et al., 1995), a previously identified Ced-3/ICE 
family member (Fernandes-Alnemri et al., 1994). 
We show here that STS-induced PCD in many cell types 
can be suppressed by a cell-permeable tripeptide designed 
to inhibit members of the Ced-3/ICE family of proteases. 
Furthermore, we show that CPP32 is activated and PARP 
is  cleaved in  STS-induced PCD  and  that  Bcl-2  inhibits 
both CPP32 cleavage and PCD induced by STS. Most im- 
portant, we show that intracellular injection of Ac-DEVD- 
CHO but not Ac-YVAD-CHO blocks STS-induced PCD, 
indicating that STS-induced PCD in some cells at least re- 
quires CPP32, or a CPP32-1ike member of the Ced-3/ICE- 
family of proteases, but not ICE itself. 
Materials and Methods 
Animals and Materials 
(Balb/c ×  C57BI/6)F1 mice were obtained from Harlan UK Ltd. (Beices- 
ter,  UK) and maintained in the Animal Facility  at  University College 
London.  Benzyloxycarbonyl-Val-Ala-Asp(O-methyl)-fluoromethylke- 
tone (Z-Val-Ala-Asp(O-Me)-CH2F; zVAD-fmk) and Benzyloxycarbonyl- 
Phe-Ala-fluoromethylketone  (zFA-fmk)  were  from  Enzyme  Systems 
Products,  Inc.  (Dublin,  CA).  Acetyl-Tyr-Val-Ala-Asp-aldehyde  (Ac- 
YVAD-CHO) was from  BAChem  (Switzerland).  Acetyl-Asp-Glu-Val- 
Asp-aldehyde (Ac-DEVD-CHO) was a gift from D. Nicholson (Merck- 
Frosst, Montreal). Stock solutions of peptide inhibitors (25-100 mM) were 
prepared in dry DMSO and stored in aliquots at  -80°C. Working dilu- 
tions were made in cell culture medium immediately before use. Calcein- 
AM and ethidium homodimer were from Molecular Probes-Europe (Am- 
sterdam). STS was a gift from Dr. H. Nakano, Tokyo Research Laborato- 
ries, Kyowa Hakko Kogyo Co. Ltd. All other chemicals were from Sigma 
(UK), unless otherwise indicated. 
Cell and Explant Cultures 
GM701, an SV40-transformed human fibroblast cell line, GM701 cells sta- 
bly transfected with the bcl-2 gene (GM701/bcl-2 cells; Jacobson et al., 
1993),  Rat-l, a  rat fibroblast cell line, and Rat-1 cells stably transfected 
with the viral ICE-inhibitor gene crmA  (Rat-1/crmA cells; Miura et al., 
1993;  a  gift of J. Yuan) were maintained in Dulbecco's Modified Eagle 
Medium containing glucose, Glutamax-1 and sodium pyruvate (DMEM, 
Gibco), and supplemented with gentamycin (50 ~g/ml) and 10% (vol/vol) 
FCS  (Gibco).  GM701  cytoplasts were prepared  as previously described 
(Jacobson et al., 1994).  Chinese hamster ovary (CHO) cells were main- 
tained in MEM-ot medium (Gibco), supplemented with gentamycin and 
5% FCS. SKW6.4 cells (Dhein et al., 1992),  a  human B-cell lymphoma 
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and glutamax-1 (Gibco), supplemented with gentamycin and 10%  heat- 
inactivated FCS. Cell lines were maintained at 37°C in either 5% (SKW 
6.4 cells) or 10% (GM701 and CHO cells) CO2 in air. 
Organ explant cultures were prepared from freshly isolated mouse or- 
gans. Small plugs of tisuse were cultured on agarose platforms in 35-mm 
Falcon  bacteriological  dishes, containing 0.5  ml DMEM  supplemented 
with 10%  FCS, as described in the accompanying paper by Weil et al. 
(1996). Forepaws were dissected from embryonic day 13.5 (E13.5) mice 
and cultured as described for organ explants. The two forepaws from each 
animal were always kept paired, one treated and one untreated, for com- 
parisons between experimental and control groups. In PCD inhibition ex- 
periments, zVAD-fmk (100 p~M) or vehicle (0.2% DMSO) was added at 
the beginning of the experiment. 
Survival and PCD Assays 
For assays on unfixed cells, bisbenzimide (HOECHST 33342) was used to 
stain nuclei, and calcein-AM and ethidium homodimer were used to as- 
sess plasma membrane integrity, as previously described (Jacobson et al., 
1994).  The colorometric MTT assay (Mosmann, 1983)  was performed on 
cells or cytoplasts grown in 96-well Falcon tisuse-culture plates, as previ- 
ously described (Jacobson et al., 1994). 
PCD in fixed cultured cells was assessed by nuclear morphology after 
staining  with  propidium  idodide  (PI)  or  bisbenzimide  (HOECHST 
33258).  For  microinjection  experiments,  cells  were  grown  on  poly-D- 
lysine-coated glass coverslips in a 60-mm Falcon tisuse-culture plate. Af- 
ter injection the cells were transferred to a  24-well tisuse-culture plate, 
and, after STS treatment, fixed in 4% paraformaldehyde in 0.1  M  phos- 
phate buffer (pH 7.4) for ~  1 h at room temperature. After centrifugation 
to attach floating cells, the cells were postfixed in 50% Carnoy's fixative 
(acetic-acid/methanol, 1:3)  in PBS, followed by 100%  Carnoy's fixative 
(with centrifugation after each step). The cells were then air dried, stained 
with PI in the presence of RNase (Jacobson et al., 1993), and mounted on 
glass slides. Cells grown in Falcon 96-well tisuse-culture plates were fixed 
and stained with bisbenzimide as follows: cells in 0.1 ml culture medium 
were fixed by adding 0.1 ml Carnoy's fixative. The plates were centrifuged 
(1,500 rpm for 5 min), the fix solution and medium were removed and re- 
placed  with 0.1  ml fresh fix solution, and  the plates were  centrifuged 
again. The fixative was removed and the plates were allowed to dry. Dried 
plates were stored at room temperature until they were stained by adding 
0.1 ml PBS containing 0.1  i~g/ml HOECHST 33258.  Nuclei were assessed 
in  an  Olympus OMT2  inverted  fluorescence microscope, using a  long 
working-distance objective, at a final magnification of 400. 
PCD in explants was assessed by a combination of the TdT-mediated 
dUTP-biotin nick end labeling (TUNEL) technique (Gavrieli et al., 1992) 
and PI staining of cryosections after paraformaldehyde fixation, as de- 
scribed in the accompanying paper by Weil et al. (1996). 
PCD in mouse paw explants was assessed by neutral red staining, based 
on the method in Milligan et al. (1995). To quantitate the regression of in- 
terdigital web tissue, web length (WL) was measured in low-power light 
micrographs of whole fixed paws as follows: WL was taken as the height 
of the web triangle formed by two digit tips as the base and the proximal 
end of the interdigital web as the vertex. This distance was normalized to 
digit length (DL), defined as the average distance between the flanking 
digit tips and the middle of the second phalanx. The WL/DL ratio was av- 
eraged for the two webs flanking the central digit of each paw. 
Plotting Inhibition Curves 
The  %  inhibition at inhibitor concentration c  was defined as:  %I(c)  = 
{(S(c)  -  MIN)/(MAX -  MIN)} x  100, where S(c) is the % survival at in- 
hibitor concentration c, MIN is the % survival without inhibitor, MAX is 
the % survival without PCD inducer or inhibitor. Data (%I vs c) were fit 
to the sigmoid logistic equation %I(c)  =  100 ×  {1/((ICso/c)  h +  1)}, where 
IC50 is the inhibitor IC50 and h is the Hill coefficient. 
Assays of PARP and CPP32 Cleavage 
PARP cleavage was assayed by Western blotting of whole-cell extracts us- 
ing a monoclonal anti-PARP antibody and the ECL method (Amersham), 
according to manufacturer's instructions. Cells grown on 60-mm Falcon 
tisuse culture dishes were harvested by brief trypsinization, and both cells 
and culture supernatant (containing floating dead cells) were collected in 
50-ml tubes containing DMEM/10% FCS. The cells were washed once in 
1 ml PBS, resuspended at 5 ×  105 cells/60 }xl in sample buffer (SB; 125 mM 
Tris, pH 6.95, 15% sucrose, 4% SDS, 10 mM EDTA, 0.001% bromophe- 
nol blue, 100 mM dithiothreitol [added fresh]) and boiled for 4 min. The 
DNA was sheared by trituration through a 23-gauge needle, and the ex- 
tracts were stored at -20°C until use. Samples (10 ixl) were boiled briefly 
and run on 7.5% SDS-PAGE gels (mini-PROTEAN, BioRad, Richmond, 
CA), prepared using a modified Laemmli gel recipe. The proteins were 
transferred from the gel to nitrocellulose, which was then blocked in PBS 
containing 0.1% Tween-20 and 5 % nonfat dry milk (PBST-M), incubated 
in the monoclonal anti-PARP antibody C-2-10 (Lamarre et al., 1988; a gift 
of W. Earnshaw, Univ. of Edinburgh, UK and G. Poirier, Universit6 Laval, 
Quebec; ascites fluid diluted 1:2,000-4,000  in PBST-M), followed by biotin- 
ylated sheep anti-mouse Ig (Amersham; diluted 1:3,000 in PBST-M) and 
then steptavidin HRP (Amersham; diluted 1:1,500 in TBST). 
CPP32 cleavage was assayed in extracts of GM701 cells prepared and 
analyzed as for PARP cleavage, only using a purified mouse anti-human 
CPP32 monoclonal antibody (Transduction Laboratories, Lexington, KY 
l:l,000 in PBST-M). To assay CPP32 cleavage in CHO cells, S100 cytoplas- 
mic extracts were prepared as described by Wang et al. (1995) and diluted 
1:1 in 2× concentrated SB. Samples were run on 15% SDS-PAGE gels, 
transferred to nitrocellulose, incubated with antibodies, and detected by 
the ECL method, as described above. The primary antibody was a rabbit 
anti-hamster CPP32 antiserum (M816-4; a gift from J. Goldstein, Univ. of 
Texas Southwestern Med. Ctr., Dallas, TX diluted 1:2,000  in PBST-M), 
followed by biotinylated  donkey anti-rabbit  Ig  (Amersham; diluted  1: 
3,000 in PBST-M), followed by streptavidin-HRP (Amersham; diluted 1: 
1,500 in PBST+ 0.5% casein). The percentage of apoptotic cells in each 
sample was determined by taking an aliquot of cells immediately after 
harvesting; the cells were plated in a  96-well tisuse-culture plate, fixed, 
and stained with bisbenzimide, as described above. 
Microinjection 
The peptide inhibitors Ac-DEVD-CHO and Ac-YVAD-CHO were seri- 
ally diluted in microinjection buffer (135 mM KC1, 15 mM NaC1,  10 mM 
Tris-HC1 [pH 7.4],  100  Ixg/ml BSA), containing lysinated FITC-Dextran 
(Molecular Probes, Eugene, OR; 10,000 mol wt, 8.3 mg/ml). Inhibitor was 
loaded at the indicated concentrations into a  pulled glass capillary tube 
and injected into cells growing on poly-o-lysine-coated, 13-mm glass cov- 
erslips. About 200 cells were injected with one concentration of inhibitor 
on each coverslip. 30 min to 3 h later, the cells were treated with 2 ~M STS 
for 8-10 h, fixed with paraformaldehyde, and stained with PI, as described 
above.  The  coverslips were  mounted in  Citifluor  (University of Kent, 
Canterbury, UK), sealed with nail varnish, and examined in a Zeiss Ax- 
ioplan fluorescence microscope. The %  inhibition of PCD (%I) was de- 
fined as {1 -  Sinj/Suninj)  } X 100,  where Sin )  and Sunin j  are  the %  survival of 
injected and uninjected cells in the same sample, respectively. 
Preimplantation  Embryos 
Four-cell embryos were obtained from 6-8-wk-old superovulated (Balb-c 
X C57Bl/6)F1 female mice mated with syngeneic males, as described in 
the accompanying paper by Weil et al. (1996).  The embryos were washed 
once in M2 medium, transferred to 0.3-ml drops of MI6 medium in 35-mm 
Falcon bacteriological culture dishes, and incubated at 37°C in 5% CO2. 
The embryos were treated within 60 rain and cell survival was assessed 36 h 
later using the vital stains HOECHST 33342,  ethidium homodimer, and 
calcein-AM. 
Results 
zVAD-fmk Inhibits STS-induced PCD in GM701 Cells 
and Cytoplasts 
To determine whether STS-induced PCD in GM701 cells 
requires  Ced-3/ICE-family proteases,  we  used  the  irre- 
versible tripeptide inhibitor Z-Val-Ala-Asp(O-Me)-fluo- 
romethylketone (zVAD-fmk), which has been shown to 
inhibit STS-induced PCD in rat hepatocytes (Cain et al., 
1996)  and a human monocytic leukemia cell line (Zhu et 
al., 1995). This inhibitor was designed to enter live cells as 
the  O-methyl ester  (of the  aspartyl carboxy side-chain) 
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Figure 1.  zVAD-fmk inhibits STS-induced PCD in GM701 cells. 
Cells in a 96-well plate were treated with 2  ixM STS in the pres- 
ence of various concentrations of zVAD-fmk for 10 h (A) or with 
100  ixM zVAD-fmk for various periods of time (B and  C). Cell 
survival was assessed by nuclear morphology after staining with 
bisbenzimide (HOECHST 33258)  in A, by nuclear morphology 
(n) and plasma membrane integrity (pm) in B, and by MTT assay 
in C. Each point represents the mean --- SEM from six wells. Each 
experiment was repeated at least once with the same results. 
hibited PCD induced by STS in the presence of 10 txg/ml 
CHX  (not  shown).  To  determine  whether zVAD-fmk- 
protected cells were also alive by other criteria, we tested 
their viability by two other assays, MTT and calcein-AM 
+  ethidium  homodimer.  MTT measures  dehydrogenase 
activity in live cells; calcein-AM labels the cytoplasm of 
live cells with an intact plasma membrane, whereas ethid- 
ium homodimer labels the nucleus of dead cells in which 
the plasma membrane has broken down. Time course ex- 
periments of STS-induced changes in nuclear morphology 
and plasma membrane integrity (Fig. 1 B), as well as in 
MTT activity (Fig. 1 C), showed that zVAD-fmk inhibited 
all of these changes for at least 36 h. Moreover, in cells ob- 
served by time-lapse video microscopy, zVAD-fmk pre- 
vented the cell shrinkage and loss of intracellular move- 
ments normally observed in STS-induced PCD (Jacobson 
et  al.,  1994)  (not  shown).  Thus,  STS-induced  PCD  in 
GM701 cells seems to depend on one or more Ced-3/ICE 
family proteases. 
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and to be converted by intracellular esterases into the ac- 
tive  inhibitor.  Such  peptidyl monofluoromethyl ketones 
are relatively poor nonspecific alkylating agents and have 
low reactivity toward serine proteinases, but they retain a 
high  degree  of  reactivity  towards  cysteine  proteinases 
(Shaw, 1990). Because it lacks an amino acid in the $4 po- 
sition, zVAD-fmk would be expected to have a  broader 
specificity for Ced-3/ICE family proteases than  the  tet- 
rapeptide  inhibitors  of this  family  such  as  Ac-DEVD- 
CHO and Ac-YVAD-CHO. 
As shown in Fig. 1 A, zVAD-fmk completely inhibited 
STS-induced PCD in GM701 cells, when cell viability was 
assessed  by nuclear  morphology.  The  apparent  IC50 of 
zVAD-fmk was  N7  txM. zVAD-fmk also completely in- 
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Figure 2.  zVAD-fmk inhibits STS-induced PCD in GM701 cells 
(A) and cytoplasts (B). Cells (43,000/well) and cytoplasts (15,000/ 
well) in 96-well plates were treated with 100  p.M zVAD-fmk or 
were left untreated,  and 2 I~M STS was added after 20 min. Cell 
survival was assessed by MTT assay. Each point represents the 
mean absorbance  _+ SEM from six wells (after background sub- 
traction)  normalized  to  the  value  obtained  from  wells treated 
with zVAD-fmk alone for each time point. The relative loss of 
MTT activity in the (zVAD-fmk +  STS)-treated cells (A) reflects 
the antiproliferative effect of STS, rather than PCD. 
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cytoplasts.  As shown in Fig.  2, cytoplasts prepared  from 
GM701 cells died (as assessed by loss of MTT activity) af- 
ter treatment  with STS, just like the nucleated cells, and 
zVAD-fmk inhibited the STS-induced loss of MTF activ- 
ity in both the cytoplasts and nucleated cells. Therefore, at 
least one of the relevant zVAD-fmk-inhibitable proteases 
is present in the cytoplasm and can be activated in the ab- 
sence of a nucleus. 
zVAD-fmk Does Not Inhibit Cell Proliferation, Even 
in the Presence of a PCD-inducing Stimulus 
If zVAD-fmk is to be useful as a tool, in studying the role 
of PCD in developmental processes, for example, it is im- 
portant that it not inhibit other cell functions such as cell 
proliferation. To test whether cells protected from PCD by 
zVAD-fmk are still able to proliferate,  we had to turn to 
an alternative inducer of PCD, as STS inhibits cell prolif- 
eration when used at the high concentrations required to 
induce PCD (Abe et al., 1991; Bruno et al., 1992; Crissman 
et al., 1991), even when cells are protected from PCD by 
zVAD-fmk  (see  Fig.  2  A)  or  bcl-2 overexpression  (not 
shown). As shown in Fig. 3 A, zVAD-fmk completely in- 
hibited  anti-APO-1/Fas-antibody  induced  PCD  (as  as- 
sessed by nuclear morphology) in the human B-cell lym- 
phoma line SKW 6.4 and was about ten times more potent 
in doing so than in inhibiting  STS-induced PCD in these 
cells. A  dipeptide-fmk (zFA-fmk), designed as a cathepsin 
B  inhibitor (Rasnick, 1985), which would not be expected 
to bind to Ced-3/ICE proteases, had no effect, even at 300 
p~M. As shown in Fig. 3 B, 100 ~M zVAD-fmk had no ap- 
parent effect on the growth rate of SKW 6.4 cells for 48 h, 
even in the presence of anti-APO-1/Fas antibodies (in this 
experiment,  anti-APO-1/Fas, in the absence of inhibitor, 
was  not  simply  cytostatic,  as  most  of the  trypan  blue- 
excluding cells, defined as viable, appeared shrunken and 
were  probably  apoptotic).  Therefore  zVAD-fmk  seems 
not to inhibit cell proliferation, and, in some cases at least, 
cells can still proliferate in the presence of a PCD-inducing 
stimulus, if zVAD-fmk is protecting them from PCD. 
STS-induced Activation of Ced-31ICE-Family Proteases 
Occurs with a 2-3-h Delay 
To  determine  when  the  Ced-3/ICE-family proteases  are 
activated after STS treatment, we treated GMT01 cells with 
zVAD-fmk at various times before or after adding 2  }xM 
STS.  As shown in Fig. 4, cells  treated  with  STS without 
zVAD-fmk were not apoptotic at 3 h  but were all apop- 
totic  by  4  h;  cotreatment  with  10  p~g/ml cycloheximide 
(CHX) did not alter the kinetics of death (not shown). By 
contrast, when cells were treated with zVAD-fmk as late as 
2 h after the addition of STS, they were still nearly all alive 
after 10 h; treatment with inhibitor 4 h after STS addition, 
however, failed to protect the cells, while addition 3 h af- 
ter STS addition protected ~40%  of them. These findings 
suggest that the relevant  Ced-3/ICE-family proteases  are 
activated  just  before  the  onset  of  apoptosis,  and  when 
these proteases become active, cell death occurs quickly. 
PARP and CPP32 Are Cleaved in STS-induced PCD 
To determine whether CPP32, or a CPP32-1ike protease, is 
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Figure 3.  zVAD-fmk inhibits  anti-Fas/APO-l-induced PCD in 
SKW6.4 cells (A), but not their proliferation (B). In A, cells in a 
96-well plate were treated with zVAD-fmk or the control peptide 
zFA-fmk 30 min before the addition of anti-Fas/APO-1 antibody 
(50 ng/ml)  or STS (2 I~M) for 7 h; viability  was assessed by nu- 
clear morphology after fixation.  The  %  inhibition  data  shown 
represent  %  survival  normalized to the maximum (no inducer) 
and minimum (no inhibitor) values.  Survival in the absence of in- 
hibitor was 12% for anti-Fas/APO-l-treated cells, and 20% for 
STS-treated cells; survival in the absence of inducer was 93%. In 
B, cells in a 24-well plate were treated with anti-Fas/APO-1 anti- 
body (50 ng/ml),  with or without zVAD-fmk (100 ixM), and ali- 
quots of cells were sampled at various times; cell viability was as- 
sessed  by trypan blue  exclusion.  Doubling  times  (h  -+  SEM) 
obtained from fitting the data to a single exponential were no in- 
hibitor,  19.8  --- 1.4; zVAD-fmk, 21.9  _+  1.6; anti-Fas/APO-1  + 
zVAD-fmk, 19.4  _+  1.5. Anti-Fas/APO-1 alone was not simply 
cytostatic; although most of the cells in these cultures excluded 
trypan blue, by 6 h most were shrunken and probably apoptotic 
(as in A). The experiments shown in A and B were repeated once 
with the same results. 
activated  during  STS-induced  PCD,  we  first  looked  for 
PARP cleavage, using Western blotting of extracts of STS- 
treated  GM701  cells,  as  PARP is  a  known substrate  for 
CPP32 (Nicholson et al.,  1995).  As shown in Fig. 5, STS 
treatment induced PARP cleavage and produced an ~85-kD 
fragment,  as  expected  for  cleavage  by  CPP32.  PARP 
cleavage occurred with the same time course (Fig. 5 A) as 
the appearance of pyknotic nuclei (see Fig. 4) and did not 
occur in cells protected with zVAD-fmk (Fig. 5 B). 
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Figure 4.  The effect of delayed addition of zVAD-fmk. GM701 
cells in a 96-well plate were treated either with 2 ~M STS alone 
for the times indicated (open circles) or with 2 txM STS for 10 h, with 
100 ixM zVAD-fmk added at various times relative to the start of 
STS treatment (closed  circles). The drugs were added in a stag- 
gered manner so that all cells were fixed at the same time at the 
end of the experiment. Cell survival was assessed  as in Fig. 1 A. 
Each point represents the mean -  SEM of results from six wells. 
Survival values were normalized to the survival with STS at time = 0 
without inhibitor, which was 93%. 
We next examined whether CPP32 itself was cleaved in 
STS-treated cells. As shown in Fig. 6  A, the 32-kD pro- 
form of CPP32 was cleaved in STS-treated GM701  cells 
with the same time course as PARP cleavage (cf. Fig. 5 A), 
and this cleavage was markedly inhibited in cells protected 
by either zVAD-fmk (Fig. 6  B)  or by overexpression of 
Bcl-2 (Fig. 6  C).  As the  antibody used to detect human 
CPP32  did not detect the  cleavage products,  we  used  a 
hamster-specific antiserum raised against an NH2-terminal 
peptide of the p20 subunit of hamster CPP32 (Wang et al., 
1996)  to  study extracts  of STS-treated Chinese hamster 
ovary (CHO) cells. As shown in Fig. 6 D, pro-CPP32 was 
cleaved  in  these  cells  to  a  17-kD  product  with  a  time 
course identical to the occurrence of PCD (determined in 
the same experiment and shown at the bottom of Fig. 6 
Figure 6.  CPP32 cleavage in STS-treated GM701 and CHO cells, 
assessed  by Western blotting. In A  and B STS-treated GM701 
cell lysates from the experiment shown in Fig. 5 were run on 15 % 
SDS-PAGE gels, and Western blots were performed with a mono- 
clonal anti-human  CPP32 antibody, as described in Materials and 
Methods. A  time course of CPP32 cleavage following 2 p.M STS 
treatment is shown in A, and inhibition  by 100 ~M zVAD-fmk is 
shown in B; in both, a whole cell lysate from Jurkat cells (sup- 
plied by Transduction Laboratories) was used as a positive con- 
trol. In C, S100 cytoplasmic fractions of GM701 and GM701/bcl-2 
cells, either untreated or treated with 2 Ixm STS for 9 h, were ana- 
lyzed as in A and B. In D, S100 cytoplasmic fractions of CHO cells 
treated with 2 ixM STS were analyzed by Western blotting, as de- 
scribed for the GM701 cell lysates,  using a rabbit anti-hamster 
CPP32 antiserum. 32-kD pro-CPP32 is indicated by arrowheads, 
and the 17-kD cleavage product in D by an asterisk. The propor- 
tion of apoptotic cells in each sample in C and D is shown at the 
bottom of each lane; the experiment in C was repeated twice with 
the same results.  The additional bands seen at ,-~68 kD in A-C 
and >32 kD in D are probably not CPP32-related, as they are un- 
affected  by the experimental conditions; they show that equiva- 
lent amounts of protein were loaded in each lane. 
Figure 5.  PARP cleavage  in STS-treated GM701 cells, assessed 
by Western blotting. (A) Time course in 2 txM STS. (B) Effect of 
100 ixM zVAD-fmk on cells treated with 2 I~M STS. Cell lysates 
were run on 7.5% SDS-PAGE gels, transferred to nitrocellulose, 
incubated in a monoclonal  anti-PARP antibody and visualized by 
ECL, as described in Materials and Methods. 
D),  and this  cleavage was  greatly inhibited in cells pro- 
tected  with  zVAD-fmk  (right-hand  lane  in  Fig.  6  D). 
Taken together, these experiments suggest that CPP32 is 
activated  in  STS-induced PCD,  at  least  in  GM701  and 
CHO cells. 
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CHO, inhibits STS-induced PCD in GM701 cells. Cells on cover- 
sfips were injected with Ac-DEVD-CHO, Ac-YVAD-CHO, or buf- 
fer alone, along with FITC-Dextran to identify the injected cells. 
After injection, the cells were treated with 2 I~M STS for 8--10 h, 
and the proportions of injected and uninjected cells with pyknotic 
nuclei were determined following paraformaldehyde fixation and 
staining with PI (A). Each point represents cells  on a separate 
coverslip, and each type of symbol represents a separate experi- 
ment. Percent inhibition of PCD was calculated as described in 
Materials  and Methods, and represents  data normalized to the 
STS-induced PCD Depends on CPP32 or a 
CPP32-1ike Protease(s) 
The above experiments indicated that CPP32 is cleaved in 
STS-induced PCD, but they did not indicate whether this 
cleavage is required for STS-induced PCD. To determine 
whether CPP32, or a  CPP32-1ike protease, is required for 
STS-induced PCD, we microinjected the tetrapeptide CPP32 
inhibitor  Ac-DEVD-CHO  (along  with  FITC-Dextran  to 
mark  the  injected  cells)  into  cultured  GM701  cells  and 
then treated the cells with STS. The cells were fixed 8-10 h 
later and assayed for PCD by analyzing nuclear morphol- 
ogy.  As  shown  in  Fig.  7,  cells  microinjected  with  Ac- 
DEVD-CHO  were  protected  against  STS-induced  PCD: 
whereas, on average, 88 +_ 7% of the uninjected and 79 _+ 
9%  of the vehicle-injected  cells were apoptotic, less than 
10%  of the cells injected with the highest concentrations 
of the  inhibitory  peptide  were  apoptotic.  The  apparent 
ICs0 for Ac-DEVD-CHO was  9  IxM in  the  injection  pi- 
pette.  Assuming an injection volume of --d-10%  of total 
cell volume, this corresponds to an intracellular concentra- 
tion of ~0.1-1  IxM. Even when 1 mM (10--100 ixM intra- 
cellular) Ac-YVAD-CHO was injected, there was no pro- 
tective effect, suggesting that ICE itself was not required 
for STS-induced PCD. 
To test further whether ICE is required for STS-induced 
PCD, we examined a stably transfected line of Rat-1 cells 
that overexpresses the Cowpox virus protein CrmA (Rat- 
1/crmA cells, Miura et al., 1993), which is a  potent inhibi- 
tor of ICE (Ray et al., 1992). When overexpressed, CrmA 
has  been  shown  to  inhibit  anti-Fas/APO-1  and  TNFet- 
induced PCD (Enari et al.,  1995b; Los et al., 1995; Miura 
et  al.,  1995;  Tewari  and  Dixit,  1995).  Rat-1/crmA  cells, 
however,  were just  as  sensitive  to  STS-induced  PCD  as 
control Rat-1 cells (not shown), consistent with the conclu- 
sion that  STS-induced  PCD does not depend  on ICE, at 
least in Rat-1 and GM701 cells. 
zVAD-fmk Inhibits STS-induced PCD in Many Cell 
Types, but Not Blastomeres 
High concentrations of STS, in the presence of cyclohex- 
imide to inhibit protein synthesis, induce PCD in all of the 
many nucleated mammalian cell types we have examined. 
To test whether Ced-3/ICE family proteases  are involved 
in most of these cases, we studied two types of primary cul- 
ture  systems that  we had  studied  previously,  explants  of 
newborn mouse organs (see accompanying paper by Weil 
et  al.  [1996]),  and  dissociated  cells  from E13 mouse em- 
bryos (minus the head and liver) (Ishizaki et al., 1995). As 
shown  in  Fig.  8,  zVAD-fmk  inhibited  (STS  +  CHX)- 
induced PCD in explant  cultures  of neonatal skin (Fig. 8 
survival of uninjected cells (Suninj) on each coverslip (Sunmj =  14 -+ 
16%, mean _+ SD for all 22 data points). The apparent IC50 de- 
rived from fitting the data to sigmoid logistic equation was 9.4 _+ 
1.9 v,M (see Materials and Methods). A confocal micrograph of 
STS-treated GM701  cells microinjected with 1 mM Ac-DEVD- 
CHO is shown in B, where the PI stained nuclei are shown in the 
top  panel  and  the  FITC-Dextran-labeled  cells  in  the  bottom 
panel. The non-apoptotic nuclei of injected cells are indicated by 
arrowheads. Bar, 50 v~m. 
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cells. (A) PI- and TUNEL-labeled sections of neonatal skin ex- 
plants treated with vehicle (0.2% DMSO), zVAD-fmk (100 I~M), 
STS (10 txM) + CHX (10 ~g/ml), or STS + CHX + zVAD-fmk. 
(B) Survival of 1-d-old cultures of E13 mouse embryo cells, either 
untreated or treated with STS (1 p,M) + CHX (10 p~g/ml)  with or 
without  zVAD-fmk (100 IxM) for 24 h.  (C) PARP cleavage  in 
E13 mouse embryo cells from the same experiment as shown in 
B. In C, full-length PARP and the larger cleaved form are each 
indicated by arrowheads.  Bar in (A) 100 ~m. 
A), as well as in freshly prepared cultures of El3 embryo 
cells (Fig. 8 B). Moreover, all of the detectable PARP was 
cleaved  in  lysates  prepared  from  the  (STS  +  CHX)- 
treated El3 cells, and this cleavage was greatly inhibited in 
cells that were protected by zVAD-fmk (Fig. 8 C). zVAD- 
fmk also inhibited (STS +  CHX)-induced PCD in explants 
of neonatal kidney, heart,  and lung,  and  adult lung,  kid- 
ney,  and  ear pinna  (not  shown).  These  findings  suggest 
that one or more Ced-3/ICE-family proteases are required 
for (STS  +  CHX)-induced PCD in most nucleated mam- 
malian cells. 
Not  all  cells,  however,  can  be  protected  from  STS- 
induced  PCD.  When  four-cell  mouse  embryos  were 
treated with 10 IxM STS (with or without CHX) for 36 h, 
the cells died with the morphological features of apoptosis 
(see  accompanying paper by Weil et al.  [1996]),  even in 
the presence of 100 IxM zVAD-fmk (Table I). 
z VAD-fmk Inhibits Interdigital PCD in Developing 
Mouse Paws 
To determine whether Ced-3/ICE-family proteases are in- 
volved in the PCDs that occur during normal development 
(Glucksmann,  1951),  we  removed  the  forepaws  from 
E13.5 mouse embryos and cultured them for 26 h  on aga- 
rose platforms. During this culture period, PCD in the in- 
terdigital spaces separated the developing digits, just as it 
normally does in vivo. Treatment with zVAD-fmk greatly 
inhibited  this cell death  (assayed by neutral  red  staining 
after 5 h in culture) and largely prevented the removal of 
the interdigital webs, assessed after 26 h in culture (Fig. 9). 
Discussion 
STS-induced PCD  has been a  useful model for studying 
some of the features of the basic core machinery of PCD. 
Its main advantage as a model is that it apparently can be 
used with any nucleated mammalian cell. One of the con- 
clusions  drawn  from  the  STS  model  is  that  nucleated 
mammalian cells constitutively express all the proteins re- 
quired to undergo PCD. The reliability of this conclusion 
depends  on the  evidence that STS-induced,  and  (STS  + 
CHX)-induced, cell deaths are bona fide PCDs. Our find- 
ings and those of others (Cain et al., 1996; Mashima et al., 
1995; Zhu et al., 1995), that peptide inhibitors of the Ced- 
3/ICE  family of proteases  can  inhibit  these  deaths  in  a 
large variety of cell types, provide the strongest evidence 
that  these  deaths,  which  display the  morphological fea- 
tures of apoptosis, are bona fide PCDs. 
Another conclusion drawn from the STS model is that 
PCD does not require a nucleus and is controlled from the 
cytoplasm:  anucleate  cytoplasts  prepared  from  GM701 
cells were shown to die with the same kinetics and mor- 
phological features when treated with STS as did the par- 
Table L Effect of  zVAD-fmk on STS-induced and 
(STS  + CHX)-induced PCD in Four-Cell Mouse Blastomeres 
Live blastomeres/total  blastomeres 
EXPT 1  EXPT 2 
Treatment  (blastomeres)  (whole embryos) 
Control  (>95)*  (>95)* 
zVAD-fmk  104/115 (90)  (>95)* 
STS  ND  0/79 (0) 
STS + zVAD-fmk  ND  0/65 (0) 
STS+CHX  0.77 (0)  0/109 (0) 
STS + CHX  + zVAD-fmk  0/67 (0)  0/146 (0) 
Embryos or dissociated blastomeres  were cultured for 36 h. STS was used at 10 IxM, 
CHX at 10 iLg/ml, and zVAD-fmk at 100 I~M. Cell viability was assessed by calcein- 
AM and ethidium homodimer staining. Cell division did not occur in STS, but it did 
so in controls  and when zVAD-fmk was used alone, which made cell counting diffi- 
cult so that the total numbers of cells in these cases (indicated with an asterisk) were 
estimates. ND, not done. 
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cultures  of developing paws. (A) E13.5 mouse forepaws stained 
with neutral red after 5 h in culture  with (right paw) or without 
(left paw) 100 txM zVAD-fmk. (B) E13.5 mouse forepaws after 
26 h  in culture  with  (right paw) or without  (left paw) 100 ~M 
zVAD-fmk, showing zVAD-fmk inhibition of the loss of interdig- 
ital webs. (C) Quantitation of inhibition  of interdigital  web loss 
by zVAD-fmk. Each pair of paws from one animal (one control, 
one zVAD-fmk treated) is indicated  with the same symbol; the 
average interdigital  ratio in each condition  is indicated  with  a 
cross. The interdigital  ratios in the zVAD-fmk-treated paws were 
significantly  different  from  untreated  controls  (P  =  0.0253, 
paired t test). A-C were each from separate experiments.  In all 
three experiments, zVAD-fmk inhibited  the loss of interdigital 
webs. Bar, 1 mm. 
ent cells (Jacobson et al.,  1994).  Again, the reliability of 
this conclusion depends on the evidence that the death of 
the cytoplasts is bona fide PCD. The present finding that 
STS-induced death of cytoplasts is inhibited by zVAD-fmk 
strongly supports the claim that the STS-treated cytoplasts 
die by PCD and suggests that at least one of the relevant 
Ced-3/ICE  family members is  present  in  the  cytoplasm 
and can be activated in the absence of a nucleus. The con- 
clusion that the death program is orchestrated from the cy- 
toplasm is also supported by findings of others that Fas- 
dependent PCD can occur in cytoplasts (Nakajima et al., 
1995;  Schulze-Osthoff et  al.,  1994)  and  that  cytoplasmic 
extracts can induce apoptotic changes in isolated nuclei in 
vitro (Enari et al., 1995a; Lazebnik et al., 1993,  1994; Mar- 
tin et al., 1995; Newmeyer et al., 1994). 
We previously studied the kinetics of STS-induced PCD 
in GM701  cells, using 1 I~M STS. We found that the first 
cells started dying after ,-~2-4 h, and most died by ~8-12 h 
(Jacobson et al., 1993,  1994). In the present study we used 
a  higher  concentration  of STS  (2  ~M)  on  GM701  cells, 
and,  although there was still a  lag of 2-3 h,  most of the 
cells died by 4 h  (see Fig. 4). Although the time course of 
PCD is somewhat variable from experiment to experiment 
and from cell line to cell line, there is always a lag phase of 
at least 2 h, which is unaffected by cotreatment with CHX. 
It is not clear what happens in the 2-h lag period to induce 
PCD,  although  it  presumably involves  the  inhibition  of 
one or more protein kinases. Whatever the mechanism of 
induction,  it is clear that  the  required  Ced-3/ICE family 
proteases that  are  inhibited  by zVAD-fmk are  not  acti- 
vated until the end of the lag period, as zVAD-fmk is still 
an effective inhibitor even when added up to 2 h after STS 
is added, just before the first appearance of PCD (see Fig. 
4). Thus, once these proteases are activated, PCD follows 
very rapidly. 
The  finding  that  zVAD-fmk  blocks  (STS  +  CHX)- 
induced PCD in a wide variety of cells, including  GM701 
cells,  a  mixture of mouse embryo cells,  and  explant cul- 
tures of various newborn and adult mouse organs, suggests 
that Ced-3/ICE-family proteases are required for (STS  + 
CHX)-induced PCD in the majority of mammalian cell types. 
However,  zVAD-fmk  does  not  inhibit  STS-induced,  or 
(STS +  CHX)-induced, PCD in four-cell-stage mouse blast- 
omeres, suggesting that  zVAD-fmk cannot  be used  as  a 
universal inhibitor of PCD. It is possible that STS-induced 
death of blastomeres does not involve Ced-3/ICE family 
members, or involves family members that are resistant to 
zVAD-fmk. Alternative explanations seem more likely to 
us: blastomeres may handle the drug differently, for exam- 
ple, either excluding it, pumping it out, or inactivating it in 
some way. 
Which of the Ced-3/ICE family members are involved in 
STS-induced  PCD?  Inhibition  by zVAD-fmk provides  a 
few clues, as it is unclear which family members zVAD- 
fmk inhibits,  especially when used on live cells. We pro- 
vide two lines of evidence that suggest that  ICE itself is 
not involved. First, CrmA, which binds to and inactivates 
ICE (Ray et al., 1992), does not inhibit STS-induced PCD 
in  Rat-1  cells.  Interestingly,  CrmA  can  inhibit  anti-Fas/ 
APO-l-induced PCD and TNFa-induced PCD in cultured 
cells  (Enari  et  al.,  1995b;  Los  et  al.,  1995;  Miura  et  al., 
1995; Tewari et al., 1995) and can inhibit CPP32-associated 
PARP cleavage in vitro (Tewari et al., 1995). Presumably 
CrmA inhibits ICE and/or other related proteases that are 
involved in a proteolytic cascade upstream of CPP32 acti- 
vation and are required for anti-Fas/APO-1- and TNFot-, 
but not STS-triggered PCD. 
The second line of evidence is more direct: microinjec- 
tion of Ac-YVAD-CHO, a  potent  tetrapeptide  inhibitor 
of ICE  (Thornberry et  al.,  1992),  does  not  inhibit  STS- 
induced PCD in GM701 cells. By contrast, several lines of 
evidence suggest that CPP32 and perhaps other closely re- 
lated family members are involved in STS-induced PCD. 
First,  STS induces  PARP  cleavage in  both  GM701  cells 
and El3 mouse embryo cells with the same time course as 
it induces PCD, and the cleavage product resembles that 
produced when CPP32 cleaves PARP in vitro. Second, STS 
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CHO cells, with the same time course as it induces PCD, 
and the 17-kD product found when pro-CPP32 is activated 
by cleavage is found in STS-treated CHO cells, indicating 
that CPP32 is itself activated during STS-induced PCD in 
these cells. Wang et al. (19%) and Chinnaiyan et al. (19%) 
observed CPP32 cleavage in STS-induced PCD, and Wang 
et al.  (1996)  showed that activated  CPP32  cleaves  sterol 
regulatory  element-binding  proteins  (SREBPs)  in  PCD, 
identifying SREBPs as additional targets of active CPP32. 
Our finding that zVAD-fmk  blocks the STS-induced acti- 
vating cleavage of CPP32 suggests that zVAD-fmk  either 
inhibits at least one Ced-3/ICE  family member,  which is 
not  ICE,  upstream  of  CPP32,  or  inhibits  CPP32  from 
cleaving itself. Third, CPP32 is not activated in cells that 
are protected from PCD by overexpression of Bcl-2. This 
suggests  that Bcl-2  acts upstream  of the activation of at 
least some of the Ced-3/ICE family proteases. Fourth, and 
most  important,  microinjection  of  the  tetrapeptide  Ac- 
DEVD-CHO,  which is a more potent inhibitor of CPP32 
than of ICE,  blocks  STS-induced  PCD  in  GM701  cells. 
This finding suggests that not only is CPP32 activated, but 
the  activation  of  CPP32  and/or  a  CPP32-1ike  protease, 
such as Mch2 and Mch3/ICE-LAP3,  is required for STS- 
induced PCD in these cells. 
The discovery that Ced-3 is homologous to ICE (Yuan 
et al., 1993) provided the critical evidence that linked this 
family of proteases to PCD. This linkage may at last pro- 
vide the beginnings of a molecular definition and under- 
standing of PCD. Inhibitors of the Ced-3/ICE family such 
as zVAD-fmk may, for example, provide a specific way to 
inhibit  PCD  and  thereby  to  determine  the  function  of 
PCD in various developmental processes in vertebrates. It 
was with this in mind that we tested the ability of zVAD- 
fmk  to inhibit PCD  in a  situation where  the role of cell 
death is known, in the interdigital spaces during digit de- 
velopment. The finding that zVAD-fmk  inhibits both in- 
terdigital  PCD  and  the  removal  of the  interdigital  web 
during digit formation in  explant cultures  of developing 
mouse paws is encouraging. In independent studies, Milli- 
gan et  al.  (1995)  showed  that the peptide  inhibitor Ac- 
YVAD-CHO suppressed interdigital PCD in the develop- 
ing  chick  limb  bud  in  ovo,  although  they  did  not  test 
whether the inhibitor blocked the removal of the interdigi- 
tal webs. It will now be of interest to test these inhibitors in 
situations where the role of PCD is unknown. 
In summary, our findings help to establish STS-induced 
PCD  as a legitimate model of PCD  and add to the accu- 
mulating evidence  that points to CPP32  and/or its close 
relatives as crucial components of the death machinery in 
mammalian cells.  Our findings also demonstrate the use- 
fulness of cell-permeable inhibitors of the Ced-3/ICE fam- 
ily of proteases for studying PCD in intact cells and tissues. 
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